CDKN2A and cancer: Specifically, we describe notable findings within B2M, CDKN2A, and RNF145. These results demonstrate the utility of RegTools in discovering putative splice-associated variants and confirm the importance of integrating RNA and DNA sequencing data in understanding the consequences of somatic mutations in cancer.